Douglas E.
About Douglas E.
Douglas E. is the Director of Project Management at Bristol-Myers Squibb in Princeton, NJ, with extensive experience in pharmaceutical project management, particularly in cardiovascular and thrombosis compounds.
Director Project Management at Bristol-Myers Squibb
Douglas E. serves as the Director of Project Management at Bristol-Myers Squibb in Princeton, NJ. He has been in this role since January 2017. In his current capacity, he is accountable for maintaining clinical and regulatory timelines for Cardiovascular Assets. Additionally, he drives progress through the BMS decision point pathway for the Cardiovascular Development Program.
Previous Roles at Bristol-Myers Squibb
Before his current role, Douglas E. held the position of Director, BioPharma Project Management at Bristol-Myers Squibb in Lawrenceville, NJ for seven months in 2016. During this tenure, he was involved in overseeing various biopharma projects and supporting the co-development effort for Thrombosis Assets in collaboration with an Alliance partner.
Project Management Experience at Mylan
Douglas E. has substantial experience in project management from his time at Mylan. He served as Director, Project Management Office To CMO from 2013 to 2016 in Canonsburg, PA, and as a Senior Project Manager at Mylan Specialty from 2011 to 2013 in Basking Ridge, NJ. In these roles, he contributed to managing and guiding key pharmaceutical projects.
Earlier Consulting and Project Roles
Douglas E. holds a significant background in consultancy and project direction, including positions at Novartis and Roche Pharmaceuticals. He was a Consultant to Novartis through On-Assignment from 2010 to 2011, and a Consultant to Roche Pharmaceuticals via Eberhardt Consulting, LLC in 2010. His tenure at Roche Pharmaceuticals consisted of multiple roles, such as Project Director in Diabetes and Medical Affairs, and Statistical Leader.
Educational Background in Pharmaceutical and Statistical Studies
Douglas E. has a robust educational background with a focus on pharmaceutical and statistical studies. He earned an MBA in Pharmaceutical Studies from Fairleigh Dickinson University (1996-1998). He also holds two MS degrees from Rutgers University in Statistics (1987-1989) and Biometrics (1984-1987), and a BS in Natural Resource Management (1980-1984). This strong academic foundation has equipped him with the expertise needed for leading complex projects in the pharmaceutical industry.